Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
G Li, E De Clercq - Nature reviews Drug discovery, 2020 - nature.com
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
[PDF][PDF] Antiviral agents for the treatment of COVID-19: Progress and challenges
M Singh, E de Wit - Cell Reports Medicine, 2022 - cell.com
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
Potential treatment methods targeting 2019-nCoV infection
LU Zheng, L Zhang, J Huang, KS Nandakumar… - European Journal of …, 2020 - Elsevier
Abstract The novel coronavirus, 2019-nCoV, has quickly spread across the world and pose
serious threat to public health because it can infect people very easily. The major clinical …
serious threat to public health because it can infect people very easily. The major clinical …
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
H Lu - Bioscience trends, 2020 - jstage.jst.go.jp
As of January 22, 2020, a total of 571 cases of the 2019-new coronavirus (2019-nCoV) have
been reported in 25 provinces (districts and cities) in China (1). Among them, 95 cases were …
been reported in 25 provinces (districts and cities) in China (1). Among them, 95 cases were …
Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV
With the current trajectory of the 2019‐nCoV outbreak unknown, public health and medicinal
measures will both be needed to contain spreading of the virus and to optimize patient …
measures will both be needed to contain spreading of the virus and to optimize patient …
[HTML][HTML] COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
[HTML][HTML] Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
L Dong, S Hu, J Gao - Drug discoveries & therapeutics, 2020 - jstage.jst.go.jp
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide,
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …
[HTML][HTML] An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …